SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

Oxford BioMedica shares fall as revenue to stay below 2022 level
17 Feb 2025

Oxford BioMedica shares fall as revenue to stay below 2022 level

(Alliance News) - Oxford BioMedica PLC on Monday said it was confident of delivering "another year of strong progress," noting strength of demand.

SMALL-CAP WINNERS & LOSERS: Wilmington half-year profit falls
17 Feb 2025

SMALL-CAP WINNERS & LOSERS: Wilmington half-year profit falls

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

LONDON BROKER RATINGS: RBC raises Ashtead; Deutsche Bank cuts Currys
3 Dec 2024

LONDON BROKER RATINGS: RBC raises Ashtead; Deutsche Bank cuts Currys

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BROKER RATINGS: HSBC upgrades Glencore to 'buy'
28 Oct 2024

LONDON BROKER RATINGS: HSBC upgrades Glencore to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

SMALL-CAP WINNERS & LOSERS: Card Factory slumps as profit falls
24 Sep 2024

SMALL-CAP WINNERS & LOSERS: Card Factory slumps as profit falls

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

LONDON BROKER RATINGS: Morgan Stanley cuts Energean
24 Sep 2024

LONDON BROKER RATINGS: Morgan Stanley cuts Energean

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Oxford Biomedica reports first-half revenue growth
23 Sep 2024

Oxford Biomedica reports first-half revenue growth

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements i...